Translocation t(8;16)(p11;p13) in Acute Non-Lymphocytic Leukemia: Report on Two New Cases and Review of the Literature

References

• Berard C. W., Dorfman R. F. Histopathology of malignant lymphomas. Clin. Haematol 1974; 3: 39–76
   Google Scholar
• Lennert K. Pathologie der Halslymphknoten: Ein abriss fuer Pathologen, Kliniker and Aerzte. Springer-Verlag, Berlin, Gottingen, Heidelbeg, New York 1964
   Google Scholar
• Weisenburger D. D., Kim H., Rappaport H. Mantle zone lymphoma. A follicular variant of intermediate lymphocytic lymphoma. Cancer 1982; 49: 1429–1438
   PubMed Web of Science ®Google Scholar
• Raffeld M., Jaffe E. S. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 1991; 78: 259–263
   PubMed Web of Science ®Google Scholar
• Banks P. M., Chan J., Cleary M. L., Delsol G., Wolf-Peeters C. D., Gatter K., Grogan T. M., Harris N. L., Isaacson P. G., Jaffe E. S., Mason D., Pileri S., Ralfkiaer E., Stein H., Wamke R. A. Mantle cell lymphoma; A proposal for unification of morphologic, immunologic, and molecular data. Am. J. Surg. Pathol 1992; 16: 637–640
   PubMed Web of Science ®Google Scholar
• Weisenburger D. D., Sanger W. G., Armitage J. O., Purtilo D. T. Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings. Blood 1987; 69: 1617–1621
   PubMed Web of Science ®Google Scholar
• Leroux D., Marchadour F. L., Gressin R., Jacob M. C., Keddari E., Monteil M., Cailiot P., Jalbert P., Sotto J. J. Non-Hodgkin's lymphomas with t(11;14) (q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma?. Br. J. Haemtol 1991; 77: 346–353
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Yunis J., Onorato-Showe L., Erikson J., Nowell P. C., Croce C. M. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224: 1403–1406
   PubMed Web of Science ®Google Scholar
• Arnold A., Kim H. G., Gaz R. D., Eddy R. L., Fukushima Y., Byers M. G., Shows T. B., Kronenberg H. M. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a paratyroid adenoma. J. Clin. Invest 1989; 83: 2034–2040
   PubMed Web of Science ®Google Scholar
• Motokura T., Bloom T., Kim H. G., Juppner H., Ruderman J., Kronenberg H. M., Arnold A. A novel cyclin encoded by a bell-linked candidate oncogene. Nature 1991; 350: 512–515
   PubMed Web of Science ®Google Scholar
• Rosenberg C. L., Wong E., Petty E. M., Bale A. E., Tsujimoto Y., Harris N. L., Arnold A. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA 1991; 88: 9638–9642
   PubMed Web of Science ®Google Scholar
• Seto M., Yamamoto K., Iida S., Akao Y., Utsumi K. R., Kubonishi I., Miyoshi I., Ohtsuki T., Yawata Y., Namba M., Motokura T., Arnold A., Takahashi T., Ueda R. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 1992; 7: 1401–1406
   PubMed Web of Science ®Google Scholar
• Oka K., Ohno T., Kita K., Yamaguchi M., Takakura N., Nishii K., Miwa H., Shirakawa S. PRAD1 gene over-expression in mantle cell lymphoma but not in other low grade B-cell lymphomas, including extranodal lymphoma. Br. J. Haematol 1994; 86: 786–791
   PubMed Web of Science ®Google Scholar
• Rimokh R., Berger F., Delsol G., Charrin C., Bertheas M. F., Ffrench M., Garoscio M., Felman P., Coiffier B., Bryon P. A, Rochet M., Gentilhomme O., Germain D., Magaud J. P. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11 q 13)-bearing leukemias. Blood 1993; 81: 3063–3067
   PubMed Web of Science ®Google Scholar
• Bosch F., Jares P., Campo E., Lopez-Guillermo A., Piris M. A., Villamor N., Tassies D., Jaffe E. S., Montserrat E., Rozman C., Cardesa A. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726–2732
   PubMed Web of Science ®Google Scholar
• Swerdlow S. H., Habeshaw J. A., Murray L. J., Dhaliwal H. S., Lister T. A., Stansfeld A. G. Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. Am. J. Pathol 1983; 113: 181–197
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K. C., Cleary M. L., Delsol G., Wolf-Peeters C. D., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Hummel M., Tamaru J., Kalvelage B., Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994; 84: 403–407
   PubMed Web of Science ®Google Scholar
• Kuppers R., Zhao M., Hansmann M., Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993; 12: 4955–4967
   PubMed Web of Science ®Google Scholar
• Duggan M. J., Weisenburger D. D., Ye Y. L., Bast M. A., Pierson J. L., Linder J., Armitage J. O. Mantle zone lymphoma: A clinicopathologic study of 22 cases. Cancer 1990; 66: 522–529
   PubMed Web of Science ®Google Scholar
• Van Den Berghe H., Parloir C., David G., Michaux J. L., Sokal G. A new characteristic karyotypic anomaly in lymphoproliferative disorders. Cancer 1979; 44: 188–195
   PubMed Web of Science ®Google Scholar
• Williams M. E., Swerdlow S. H., Rosenberg C. L., Amold A. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Research 1992; 52: 5541–5544
   PubMed Web of Science ®Google Scholar
• Meeker T. C., Grimaldi J. C., Rourke R. O'., Louie E., Juliusson G., Einhorn S. An additional breakpoint region in the BCL-1 locus associated with the t(11;14) (q13;q32) translocation of B-lymphocytic malignancy. Blood 1989; 74: 1801–1806
   PubMed Web of Science ®Google Scholar
• Meeker T. C., Sellers W., Harvey R., Withers D., Carey K., Xiao H., Block A. M., Dadey B., Han T. Cloning of the t(11;14) (q13;q32) translocation breakpoints from two human leukemia cell lines. Leukemia 1991; 5: 733–737
   PubMed Web of Science ®Google Scholar
• Rimokh R., Berger F., Delsol G., Digonnet I., Rouault J. P., Tigaud J. D., Gadoux M., Coiffier B., Bryon P. A., Magaud J. P. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell. Lymphomas 1994; 83: 1871–1875
   Google Scholar
• Stetler-Stevenson M., Raffeld M., Cohen P., Cossman J. Detection of occult follicular lymphoma by specific DNA amplification. Blood 1988; 72: 1822–1825
   PubMed Web of Science ®Google Scholar
• Withers D. A., Harvey R. C., Faust J. B., Melnyk O., Carey K., Meeker T. C. Characterization of a candidate bcl-1 gene. Mol. Cell. Biol 1991; 11: 4846–4853
   PubMed Web of Science ®Google Scholar
• Komatsu H., Iida S., Yamamoto K., Mikuni C., Nitta M., Takahashi T., Ueda R., Seto M. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. Blood 1994; 84: 1226–1231
   PubMed Web of Science ®Google Scholar
• Yoshida M. C., Wada M., Satoh H., Yoshida T., Sakamoto H., Miyagawa K., Yokota J., Koda T., Kakinuma M., Sugimura T., Terada M. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Proc. Natl. Acad. Sci. USA 1988; 85: 4861–4864
   PubMed Web of Science ®Google Scholar
• Casey G., Smith R., McGillivray D., Peters G., Dickson C. Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol. Cell. Biol 1986; 6: 502–510
   PubMed Web of Science ®Google Scholar
• Akiyama N., Tsuruta H., Sasaki H., Sakamoto H., Hamaguchi M., Ohmura Y., Seto M., Ueda R., Hirai H., Yazaki Y., Sugimura T., Terada M. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14) (q13;q32). Cancer Res 1994; 54: 377–379
   PubMed Web of Science ®Google Scholar
• Jadayel D., Matutes E., Dyer M. J. S., Brito-Babapulle V., Khohkar M. T., Oscier D., Catovsky D. Splenic lymphoma with villous lymphocytes: Analysis of BCL-1 rearrangements and expression of the cyclin D1 gene. Blood 1994; 83: 3664–3671
   PubMed Web of Science ®Google Scholar
• Yang W. I., Zukerberg L. R., Motokura T., Arnold A., Harris N. L. Cyclin D1 (Bcl-1, PRAD1) protein expression in lowgrade B-cell lymphomas and reactive hyperplasia. Am. J. Pathol 1994; 145: 86–96
   PubMed Web of Science ®Google Scholar
• Xiong Y., Connolly T., Futcher B., Beach D. Human D-Type cyclin. Cell 1991; 65: 691–699
   PubMed Web of Science ®Google Scholar
• Baldin V., Lukas J., Marcote M. J., Pagano M., Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7: 812–821
   PubMed Web of Science ®Google Scholar
• Matsushime H., Ewen M. E., Strom D. K., Kato J., Hanks S. K., Roussel M. F., Sherr C. J. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992; 71: 323–334
   PubMed Web of Science ®Google Scholar
• Serrano M., Hannon G. J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704–707
   PubMed Web of Science ®Google Scholar
• Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701–704
   PubMed Web of Science ®Google Scholar
• Polyak K., Lee M. H., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P., Massague J. Cloning of p27Kipl a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59–66
   PubMed Web of Science ®Google Scholar
• Dowdy S. F., Hinds P. W., Louie K., Reed S. I., Arnold A., Weinberg R. A. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993; 73: 499–511
   PubMed Web of Science ®Google Scholar
• Buchkovich K., Duffy L. A., Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1007–1105
   Web of Science ®Google Scholar
• DeCaprio J. A., Ludlow J. W., Lynch D., Fukuhara Y., Griffin J., Piwnica-Worms H., Huang C. M., Livingston D. M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58: 1085–1095
   PubMed Web of Science ®Google Scholar
• Muller H., Lukas J., Schneider A., Warthoe P., Bartek J., Eilers M., Strauss M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA 1994; 91: 2945–2949
   PubMed Web of Science ®Google Scholar
• Xiong Y., Zhang H., Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71: 505–514
   PubMed Web of Science ®Google Scholar
• Pagano M., Theodoras A. M., Tam S. W., Draetta G. F. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev 1994; 8: 1627–1639
   PubMed Web of Science ®Google Scholar
• Hinds P. W., Dowdy S. F., Eaton E. N., Arnold A., Weinberg R. A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 1994; 91: 709–713
   PubMed Web of Science ®Google Scholar
• Lovec H., Grzeschiczek A., Kowalski M. B., Moroy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 1994; 13: 3487–3495
   PubMed Web of Science ®Google Scholar
• Rosenberg C. L., Motokura T., Kronenberg H. M., Arnold A. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. Oncogene 1993; 8: 519–521
   PubMed Web of Science ®Google Scholar
• The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Zukerberg L. R., Medeiros J. L., Ferry J. A., Harris N. L. Diffuse low-grade B-cell lymphomas: Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am. J. Clin. Pathol 1993; 100: 373–385
   PubMed Web of Science ®Google Scholar
• Second MIC Cooperative Study Group. Morphologic, immunologic and cytogenetic (MIC). working classification of the acute myeloid leukemias. Report of the workshop held in Leuven, Belgium, September 15–17, 1986. Cancer Genet. Cytogenet 1988; 30: 1–15
   PubMed Web of Science ®Google Scholar
• Mitelman F., Heim S. Quantitative acute leukemia cytogenetics. Genes. Chrom. Cancer 1992; 5: 57–66
   PubMed Web of Science ®Google Scholar
• Schouten T. J., Hustinx T. W. J., Scheres J. M. J. C., Holland R., de Vaan G. A. M. Malignant histiocytosis, clinical and cytogenetic studies in a newborn and a child. Cancer 1983; 52: 1229–1236
   PubMed Web of Science ®Google Scholar
• Bernstein R., Macdougall L. G., Pinto M. R. Chromosome patterns in 26 south african children with acute non-lymphocytic leukemia (ANLL). Cancer Genet. Cytogenet 1984; 11: 199–214
   PubMed Web of Science ®Google Scholar
• Hogge D. E., Misawa S., Parsa N. Z., Pollak A., Testa J. R. Abnormalities of chromosome 16 in association with acute myelomonocytic leukemia and dysplastic bone marrow eosinophils. J. Clin. Oncol 1984; 2: 550–557
   PubMed Web of Science ®Google Scholar
• Ritter H. L., Jr, Weiden P. L. Unusual association of bone marrow necrosis, disseminated intravascular coagulation, and a rare 8;16 chromosomal translocation in an adult patient with acute nonlymphocytic leukemia. Cancer Genet. Cytogenet 1987; 24: 243–250
   PubMed Web of Science ®Google Scholar
• Juneja H. S., Elder F. F. B., Rajaraman S. Acute monoblastic leukemia with a single chromosomal rearrangement involving breakpoints on chromosomes 8 and 16, 46, XX, t(8;16)(p11;p13). Acta Haematol 1987; 78: 1–5
   PubMed Web of Science ®Google Scholar
• Heim S., Avanzi G. C., Billström R., Kristoffersson U., Mandahl N., Bekassy A. N., Garwick S., Wiebe T., Pegoraro L., Falda M., Resegotti L., Mitelman F. A new specific chromosomal rearrangement, t(8;16)(p11;p 13), in acute monocytic leukemia. Brit. J Haematol 1987; 66: 323–326
   PubMed Web of Science ®Google Scholar
• Bernstein R., Pinto M. R., Spector I., Macdougall L. G. A unique 8;16 translocation in two infants with poorly differentiated monoblastic leukemia. Cancer Genet. Cytogenet 1987; 24: 213–220
   PubMed Web of Science ®Google Scholar
• Lai J. L., Zandecki M., Jouet J. P., Savary J. B., Lambiliotte A., Bauters F., Cosson A., Deminatti M. Three cases of translocation (8;16)(p11;p13) observed in acute myelomonocytic leukemia: a new specific subgroup?. Cancer Genet. Cytogenet 1987; 27: 101–109
   PubMed Web of Science ®Google Scholar
• Brookwell R., Hunt F. A. Translocation (8;16) in acute myelomonocytic leukemia. Cancer Genet. Cytogenet 1988; 32: 297–298
   PubMed Web of Science ®Google Scholar
• Becher R., Haas O. A., Graeven U., Bettelheim P., Ambros P., Fridrik M., Schaefer U. W., Schmidt C. G. Translocation t(8;16) in acute monocytic leukemia. Cancer Genet. Cytogenet 1988; 34: 265–271
   PubMed Web of Science ®Google Scholar
• Powell B.L., McNay J.W., Brown S., Cooper M.R., Pettenati M. J. Translocation (8;16)(p11;p13) in patients with acute monocytic leukemias, an evolving syndrome?. Cancer Genet. Cytogenet 1988; 36: 109–115
   PubMed Web of Science ®Google Scholar
• Smadja N., De Gramont A., Gonzalez-Canali G., Krulik M. Another case of acute myelomonocytic leukemia with t(8;16)(p11;p13). Cancer Genet. Cytogenet 1988; 36: 137–139
   PubMed Web of Science ®Google Scholar
• Brizard A., Guilhot F., Huret J. L., Benz-Lemoine E., Tanzer J. The 8p11 anomaly in “monoblastic” leukaemia. Leukemia Res 1988; 12: 693–697
   PubMed Web of Science ®Google Scholar
• Zandecki M., Lai J. L., Mazingue F., Lepelley P., Chassaing O., Farriaux J. P., Deminatti M., Cosson A. Congenital acute monoblastic leukemia with double translocation (8;16)(p11;p13)and(16;20)(q13;p13). Nouv. Rev. Franç. Hémat 1988; 30: 247–250
   PubMed Web of Science ®Google Scholar
• Barbata G., Carbone P., Mirto S., Santoro A., Giglio M. C., Granata G. Translocation t(8;16)(p11;p13) in acute non-lymphoblastic leukemia (M4) possibly secondary to Hodgkin's disease. Cancer Genet. Cytogenet 1989; 37: 127–131
   PubMed Web of Science ®Google Scholar
• Bertheas M. F., Jaubert J., Vasselon C., Reynaud J., Pomier G., Le Petit J. C., Hagemeijer A., Brizard C. P. A complex t(3;8;17) involving breakpoint 8p11 in a case of M5 acute nonlymphocytic leukemia with erythrophagocytosis. Cancer Genet. Cytogenet 1989; 42: 67–73
   PubMed Web of Science ®Google Scholar
• Slovak M. L., Nemana L, Traweek S. T., Stroh J. A. Acute monoblastic leukemia (FAB-M5b) with t(8;14)(p11;q11). Cancer Genet. Cytogenet 1991; 56: 237–242
   PubMed Web of Science ®Google Scholar
• Hanada T., Ono I., Minosaki Y., Moriyama N., Nakahara S., Ohtsu A. Translocation t(8;16)(p11;p13) in neonatal acute monocytic leukemia. Eur. J. Pediat 1991; 150: 323–324
   PubMed Web of Science ®Google Scholar
• Wessels J. W., Mollevanger P., Dauwerse J. G., Cluitmans F. H. M., Breuning M. H., Beverstock G. C. Two distinct loci on the short arm of chromosome 16 are involved in myeloid leukemia. Blood 1991; 77: 1555–1559
   PubMed Web of Science ®Google Scholar
• Lai J. L., Zandecki M., Fenaux P., Preudhomme C., Facon T., Deminatti M. Acute monocytic leukemia with (8;22)(p11;q13) translocation: involvement of 8p11 as in classical t(8;16)(p11;p13). Cancer Genet. Cytogenet 1992; 60: 180–182
   PubMed Web of Science ®Google Scholar
• Hanslip J. I., Swansbury J. G. J., Pinkerton R., Catovsky D. The translocation t(8;16)(p11;p13) defines an AML subtype with distinct cytology and clinical features. Leukemia & Lymphoma 1992; 6: 479–486
   Web of Science ®Google Scholar
• Quesnel B., Kantarjian H., Bjergaard J. P., Brault P., Estey E., Lai J. L., Tilly H., Stoppa A. M., Archimbaud E., Harousseau J. L., Bauters F., Fenaux P. Therapy-related acute myeloid leukemia with t(8;21), inv(16) and t(8;16): a report on 25 cases and review of the literature. J. Clin. Oncol 1993; 11: 2370–2379
   PubMed Web of Science ®Google Scholar
• ISCN: Guidelines for cancer cytogenetics Supplement to an international system for human cytogenetic nomenclature, F. Mitelman. Karger, Basel 1991
   Google Scholar
• Marosi C., Bettelheim P., Geissler K., Lechner K., Köller U., Haas O. A., Chott A., Hagemeijer A. Translocation (16;21)(p11;q22) in acute monoblastic leukemia with erythrophagocytosis. Cancer Genet. Cytogenet 1991; 54: 61–66
   PubMed Web of Science ®Google Scholar
• Le Beau M. M., Larson R. A., Bitter M. A., Vardiman J. W., Golomb H. M., Rowley J. D. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. New Engl. J. Med 1983; 309: 630–636
   PubMed Web of Science ®Google Scholar
• Kerry F., Hyde S., Harrison P. Translocation (8;13) and T-cell lymphoma: a case report. Cancer Genet. Cytogenet 1993; 65: 71–73
   PubMed Web of Science ®Google Scholar
• Leslie J., Barker T., Jennings B., Pearson J. T(8;13 translocation in a myeloproliferative disorder associated with a T-cell non-Hodgkin lymphoma. Brit. J. Haematol 1994; 86: 876–878
   PubMed Web of Science ®Google Scholar
• MacDonald D., Sheerin S. M., Cross N. C. P., Spencer A., Goldman J. M. An atypical myeloproliferative disorder with t(8;13(p11;q12): a third case. Brit. J. Haematol 1994; 86: 879–880
   PubMed Web of Science ®Google Scholar
• Wainscoat J. S., Fey M. F., Pilkington S., Summers C., Oscier D. G. Absence of immunoglobulin and T-cell receptor gene rearrangements in myelodysplastic syndromes and acute nonlymphocytic leukemias. Am. J. Hematol 1988; 28: 95–97
   PubMed Web of Science ®Google Scholar
• Cheng G. Y., Minden M. D., Toyonaga B., Mak T. W., McCulloch E. A. T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia. J. Exp. Med 1986; 163: 414–424
   PubMed Web of Science ®Google Scholar
• Mirro J., Zipf T. F., Pui C. H., Kitchingman G., Williams D., Melvin S., Murphy S. B., Stass S. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. Blood 1985; 66: 1115–1123
   PubMed Web of Science ®Google Scholar